{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:35:13Z","timestamp":1783226113648,"version":"3.54.6"},"reference-count":24,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Chiba University Hospital","award":["CREATION-Fund; Clinical Research Initiation-Fund"],"award-info":[{"award-number":["CREATION-Fund; Clinical Research Initiation-Fund"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,4,8]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There are a substantial number of patients developing heart failure after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS), even though AS has been successfully treated. The purpose of this randomised controlled trial was to determine whether the addition of an angiotensin receptor\u2013neprilysin inhibitor (ARNI), sacubitril\/valsartan, is superior to conventional medications in lowering N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in patients undergoing TAVI for AS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The study design is a prospective, single-centre, open-label, randomised, parallel-group, two-arm study, in which participants will be randomised in a 1:1 ratio to receive either conventional medications plus ARNI or conventional medications only. In the ARNI group, if a patient was on an ACE inhibitor or angiotensin II receptor blocker before TAVI, it will be switched to ARNI 100 mg\/day (50 mg two times per day) on the first postoperative day. If not, candesartan 4 mg\/day will be started 1\u20132 days before TAVI, and switched to ARNI 100 mg\/day on the first postoperative day. As the patient has tolerability to ARNI, dosage will be increased stepwise to 400 mg\/day 2\u20134 weeks apart. ARNI will be continued until at least 6-month follow-up. In the control group, the patient will receive conventional medications. The primary endpoint is the serum NT-proBNP value at 6-month follow-up after TAVI. Each group includes 42 patients (84 total patients).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval for this study has been obtained from the Chiba University Hospital Certified Clinical Research Review Board (CRB3180015). The study is ongoing. Findings from this study will be disseminated through peer-reviewed publications and conference presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>This trial has been registered on the Japan Registry of Clinical Trials: jRCT1031220344.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-095105","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T20:05:35Z","timestamp":1745870735000},"page":"e095105","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the efficacy of angiotensin receptor\u2013neprilysin inhibitor in patients with aortic stenosis undergoing transcatheter aortic valve implantation: protocol for a randomised, open-label, controlled study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2888-6160","authenticated-orcid":false,"given":"Hideki","family":"Kitahara","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Okita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3664-1158","authenticated-orcid":false,"given":"Takeshi","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Ophthalmology, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yaginuma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Inaba","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Matsumiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"2025121403261399000_15.4.e095105.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814052"},{"key":"2025121403261399000_15.4.e095105.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816885"},{"key":"2025121403261399000_15.4.e095105.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.09.010"},{"key":"2025121403261399000_15.4.e095105.4","first-page":"413","article-title":"The Relationship Between Heart-Failure Hospitalization and Mortality in Patients Receiving Transcatheter Aortic Valve Replacement","volume":"35","author":"Nazzari","year":"2019","journal-title":"Can J Cardiol"},{"key":"2025121403261399000_15.4.e095105.5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.008959","article-title":"Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement","volume":"13","author":"Auffret","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2025121403261399000_15.4.e095105.6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014481","article-title":"Electrocardiographic Strain Pattern Is a Major Determinant of Rehospitalization for Heart Failure After Transcatheter Aortic Valve Replacement","volume":"10","author":"Heger","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025121403261399000_15.4.e095105.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.001"},{"key":"2025121403261399000_15.4.e095105.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077"},{"key":"2025121403261399000_15.4.e095105.9","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1253\/circj.CJ-21-0431","article-title":"JCS\/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"85","author":"Tsutsui","year":"2021","journal-title":"Circ J"},{"key":"2025121403261399000_15.4.e095105.10","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001063"},{"key":"2025121403261399000_15.4.e095105.11","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1908655"},{"key":"2025121403261399000_15.4.e095105.12","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1253\/circj.CJ-20-0135","article-title":"JCS\/JSCS\/JATS\/JSVS 2020 Guidelines on the Management of Valvular Heart Disease","volume":"84","author":"Izumi","year":"2020","journal-title":"Circ J"},{"key":"2025121403261399000_15.4.e095105.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923"},{"key":"2025121403261399000_15.4.e095105.14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003105","article-title":"Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction","volume":"9","author":"Savarese","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2025121403261399000_15.4.e095105.15","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314173"},{"key":"2025121403261399000_15.4.e095105.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.03.002"},{"key":"2025121403261399000_15.4.e095105.17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1253\/circj.CJ-23-0288","article-title":"Extracellular Volume Fraction by Computed Tomography Predicts Prognosis After Transcatheter Aortic Valve Replacement","volume":"88","author":"Takahashi","year":"2024","journal-title":"Circ J"},{"key":"2025121403261399000_15.4.e095105.18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12928-023-00924-z","article-title":"Contemporary issues and lifetime management in patients underwent transcatheter aortic valve replacement","volume":"38","author":"Matsushita","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"key":"2025121403261399000_15.4.e095105.19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12928-025-01094-w","article-title":"Calcium channel blocker use and outcomes following transcatheter aortic valve intervention for aortic stenosis","volume":"40","author":"Miyahara","year":"2025","journal-title":"Cardiovasc Interv Ther"},{"key":"2025121403261399000_15.4.e095105.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032839"},{"key":"2025121403261399000_15.4.e095105.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad195"},{"key":"2025121403261399000_15.4.e095105.22","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.2337\/dc24-S013","article-title":"13. Older Adults: Standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"2025121403261399000_15.4.e095105.23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005565","article-title":"Sacubitril\/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts","volume":"12","author":"Burke","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2025121403261399000_15.4.e095105.24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10557-020-06995-x","article-title":"Protection of Sacubitril\/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice","volume":"34","author":"Li","year":"2020","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-095105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:26:26Z","timestamp":1765711586000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-095105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,28]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bmjopen-2024-095105"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-095105","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}